Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to PCV13 after prior community-acquired pneumonia
NL-OMON40285Active, not recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease (2 cohorts), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Immune response to pneumococcal vaccination, Antibody titres before and after vaccination and 1 more. Started Apr 2014; status: active, not recruiting.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NL-OMON40285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40285.